The narrow health insurance networks that have become more common under the Affordable Care Act can reduce patient spending by as much as a third, according to research from MIT.
The narrow health insurance networks that have become more common under the Affordable Care Act can reduce patient spending by as much as a third, according to research from MIT.
Economist Jon Gruber found that the limited choices provided by narrow networks led to patients using more primary care and going to the emergency room less, reported Vox. Costs were down because the providers contracted with narrow networks tended to charge lower prices.
Typically, narrow networks are not popular among consumers. California’s state legislature recently approved a bill that would require insurers to prove they are providing sufficient coverage. The legislation was in response to a lawsuit from disgruntled patients alleging Anthem Blue Cross and Blue Shield of California misled consumers about the provider networks.
However, Massachusetts’ foray into narrow networks revealed their potential. In 2011, the state offered 3 months of free premiums to employees who switched to a limited network. Gruber and coauthor Robin McKnight studied both those patients who switched to narrow networks and those who did not from 2010 to 2012.
Narrow networks were offered prior to 2011, but with the financial incentive, the number of employees who switched increased by 11 percentage points. Those who chose to a limited network spent an average of 36% less on healthcare spending, according to Gruber and McKnight’s research.
Patients on narrow plans used less medical care. Although they spent 28% more on visits to primary care physicians, specialty care costs were down by 45%. Patients who switched to a narrow network went to the emergency room less—likely because they were closer geographically to their primary care physician—and got fewer x-rays and scans.
Although patients may have been concerned that cheaper hospitals and providers may not be offer good care, this was not the case in Massachusetts, according to Gruber and McKnight. There was no significant difference in quality between hospitals inside and outside of narrow network plans.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More